U.S., April 25 -- ClinicalTrials.gov registry received information related to the study (NCT07549360) titled 'Leveraging Optimal Tolerance in Undernourished Infants to Support Growth' on April 18.

Brief Summary: The goal of this study is to learn if InfaCore (IC) an energy and nutrient dense formulation (ENDF) can improve growth and tolerance in infants with or at risk of growth faltering when fed IC.

Study Start Date: May 15

Study Type: INTERVENTIONAL

Condition: Faltering Growth Failure to Thrive

Intervention: OTHER: Infant Formula

Prospective, single-center, single-arm open label pilot study to show growth and tolerance in infants with/at risk of FG/FTT when fed an ENDF for 8 weeks.

Recruitment Status: NOT_YET_RECRUITING

Sponsor...